All these scientific observations support the traditional
use of B. laciniata, C. epithymum and D. ovatum for treating Sorafenib supplier liver disorders. The free radical scavenging and antioxidant properties of phytoconstituents may be the possible mechanisms of its hepatoprotective potential. The developed formulation is more safe and effective similar to the commercial herbal formulas containing silymarin. All authors have none to declare. “
“Gastroretentive drug delivery systems (GRDDS) are reported beneficial to many drugs for improving their bioavailability, therapeutic efficacy and by possible reduction of dose. These systems offer various pharmacokinetics advantages like maintenance of constant therapeutic levels over a prolonged period and thus reduction in fluctuation in therapeutics levels minimizing the risk of resistance especially in case of antibiotics.1, 2, 3, 4 and 5 Cefdinir is a Paclitaxel concentration semi-synthetic, broad spectrum, β-lactamase-stable antibiotic in the third generation of the cephalosporin class. It was approved by the U.S. Food and Drug Administration (FDA) in December of 1997.6 Oral bioavailability of cefdinir is 20–25% and short biological half life (1–2 h).7 Cephalosporin drugs show incidence of antibiotic-associated colitis, which might
have been caused by the high concentration of antibiotic entering the colon. To avoid the drug absorption in the colon gastroretentive dosage form would be required to ensure drug delivery within drug-absorbable intestinal regions.8 Cefdinir is administered with the antacid as its activity is lost due to increase in the gastric pH suggested that the absorption of drug is confined mainly to the upper part of the gastrointestinal tract.9 Cefdinir had higher absorption in the proximal region of the GI tract and poor absorption, as well as antibiotic-associated colitis, when a large amount of drug entered the colon suggest it is an ideal candidate unless for a gastroretentive drug delivery system that will prolong
the gastric residence time of the dosage form, giving prolonged drug release in the upper GI tract, where absorption of cefdinir is well confined.8 and 9 Cefdinir was obtained as a gift sample from Aurobindo Pharma Ltd., Hyderabad, HPMC (K4M, K100M, and K15M) were kindly gifted by Dr. Reddy’s Laboratories, Hyderabad. All other materials and solvents used were of analytical grade or pharmaceutical grade. Step-1 (matrix layer): accurately weighed quantities (as specified in Tables 1 and 2)10 and 11 of cefdinir, HPMC K4M (& other polymer), MCC, sodium bicarbonate and citric acid were passed through #40 to get uniform size particles, then they were mixed geometrically for 5–10 min to ensure homogenous mass. Accurately weighed quantity of PVP K30 was dissolved in Isopropyl alcohol (IPA) which was to be used as a binder solution. The binder solution was added to the dry blend gradually with constant kneading to form homogenous mass.